{"nct_id":"NCT00730379","title":"A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)","status":"COMPLETED","status_verified_date":"2015-02","start_date":"2008-07","start_date_type":null,"primary_completion_date":"2010-11","primary_completion_date_type":"ACTUAL","completion_date":"2010-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}